Organon (NYSE: OGN) reported Q3 EPS of $1.01, $0.07 better than the analyst estimate of $0.94. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.57 billion.

GUIDANCE:

Organon sees FY2025 revenue of $6.2-6.25 billion, versus the consensus of $6.26 billion.

For earnings history and earnings-related data on Organon (OGN) click here.